Based on our competition and regional binding studies and upon comparison with the MAO-B inhibitor deprenyl, we conclude that 3H-BU99008 binds specifically to HA binding sites and its binding behaviour and properties appear to be different from those of 3H-Deprenyl in CN, and sporadic AD brains. This evidence concerns the gene MAOB and Alzheimer disease.